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The use of EBT3 film and Delta4 for the dosimetric 
verification of EclipseTM treatment planning system in 
a heterogeneous chest phantom: an IMRT technique 
INTRODUCTION 
In radiation therapy, the precision and             
accuracy of treatment planning process and dose 
delivery are significant in tumor control and 
spare normal tissue from inessential radiation 
dose (1, 2). To achieve this aim, dose calculation 
by treatment planning systems (TPSs) was            
performed precisely; hence, quality assurance 
(QA) in the radiotherapy treatment planning 
process is essential (3).  On the other hand, due to 
the complexity of the IMRT technique and the 
difficulty of treatment dose verification using 
manual calculations, it is usually suggested that 
in addition to performing the periodic tests of 
the system, plan verification and pretreatment 
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ABSTRACT 
Background: This study aimed to evaluate the dose calculation accuracy of 
EclipseTM treatment planning system (TPS) in a heterogeneous chest phantom 
with the intensity modulated radiotherapy (IMRT) technique using EBT3 film 
and Delta4. Materials and Methods: Two IMRT plans (A and B) were prepared 
for radiotherapy of the heterogeneous chest phantom. Plan A was between the left 
lung and the surrounding soft tissue and plan B was carried out on the soft tissue. 
EBT3 film and Delta4 were used for dose measurement in the phantom. EclipseTM 
TPS was also used for dose calculation. Finally, the gamma index values of the TPS 
with film and TPS with Delta4 were obtained. A 95% passing rate of gamma index 
with the passing criterion of 3mm/3% and a dose threshold of 20% as the standard 
criterion was considered in this study. Furthermore, the passing rates of gamma 
indices of the film and Delta4 were compared with each other via Bland-Altman 
analysis. Results: The mean passing rate of gamma index with standard 
passing criterion between the TPS calculations and film measurements was 
96.95±0.22%, while it was equal to 97.7±0.56% and 98.45±0.21% between 
the TPS calculations and 2D and 3D Delta4 measurements, respectively. 
Additionally, the differences between the passing rates of gamma indices of 
the film and Delta4 were less than 5%. Conclusion: The findings demonstrate 
that the accuracy of dose calculations of EclipseTM TPS in a heterogeneous 
chest phantom with the IMRT technique is within the standard passing 
criterion. Furthermore, it can be concluded that there is a good agreement 
between the film and Delta4, as IMRT QA devices.  
 
Keywords: Delta4, EBT3 film, Heterogeneous phantom, IMRT 
*Corresponding authors: 
Abolfazl Nickfarjam, PhD.,  
Fax: + 98 35 3821 1222  
E-mail: 
a.nickfarjam@ssu.ac.ir  
Revised: March 2018  
Accepted: April 2018  
Int. J. Radiat. Res., April 2019;  
17(2): 355-361 
►  Short Report 
DOI: 10.18869/acadpub.ijrr.17.2.355 
D
ow
nl
oa
de
d 
fro
m
 ijr
r.c
om
 at
 20
:45
 +0
43
0 o
n W
ed
ne
sd
ay
 M
ay
 29
th 
20
19
checks are carried out (4, 5). The most common 
method used in IMRT QA is to deliver the IMRT 
plan to a phantom and then compare the dose 
distribution measured by a detector with values 
calculated by TPS (6). 
Film dosimetry has been extensively adapted 
for use in IMRT QA because of its better spatial 
resolution, energy and dose rate independence, 
effective atomic number, a density close to tissue 
and water, etc. (7). However, ﬁlm dosimetry is a 
time-consuming method, if an acceptable level of 
accuracy is needed in absolute dose                            
determination (8). The arrays of detectors are 
used as a replacement for films for the purpose 
of assessing IMRT pretreatment QA, requiring an 
easy setup and verification methods (8). Delta4 
phantoms are diode-based detectors which have 
an acceptable linear response, reproducibility, 
and energy independence; however, they exhibit 
a lower spatial resolution than film due to the 
existing spaces between two perpendicular 
planes of diodes (9, 10). 
There are several studies which have                  
compared the dosimetric performance of QA  
devices in IMRT with a homogeneous phantom 
(10, 11). In a study, Chandraraj et al. (10) compared 
the dosimetric performance of EDR2 film and 
three other commercial QA devices (MatriXX 
array, Delta4, and PTW seven29 array). Their 
findings revealed that the four QA systems              
investigated in patient-specific IMRT QA analysis 
were equivalent. Furthermore, they suggested 
that these systems could be applied                           
interchangeably for routine patient specific QA. 
In another study, Hayashi et al. (11) investigated 
the dosimetric verification of IMAT treatment 
plans using a 2D diode array detector, polymer 
gel dosimeter and radiochromic film. They              
reported that the dose distribution                         
measurements with 2D diode array and                    
Gafchromic EBT2 films show very good                 
agreement with other calculated distributions. 
However, gamma passing rates obtained by the 
BANG3 gel measurements were lower than 
those obtained using the other measurement 
devices. 
In this research, the dose calculation accuracy 
of EclipseTM TPS was quantified in a                              
heterogeneous chest phantom with the IMRT 
356 
technique using EBT3 film and Delta4.                       
Furthermore, the gamma index values of the 
EBT3 film were compared with gamma index 
values of Delta4.  
 
 
MATERIALS AND METHODS 
 
GafchromicTMEBT3 film calibration, scanning 
and analysis 
In this study, GafchromicTM EBT3 film (ISP, 
Wayne, NJ, USA) of 8 × 10 inch was used. All 
measurements were conducted according to 
AAPM TG-55 reports (12). 
Dose levels of 10, 20, 40, 80, 120, 160, 200, 
240, and 300 cGy were used to plot the                        
calibration curve. All films were scanned with 
the Microtek 9800XL scanner (Microtek Inc.       
Santa Fe Spring, CA) after 48-h of irradiation in 
order to stabilize the active layer color. The films 
were scanned with a 150-dpi (0.17mm) spatial 
resolution at the transmission scan mode in 
three colors (48 bit RGB) and images were 
stored in tagged image file format (TIFF). Image 
analysis was performed using ImageJ software 
(National Institutes of Health, Bethesda,                   
Maryland) and the calibration curve was                  
obtained based on the proposed method by          
Devic et al. (13).  
 
ScandiDos Delta4 phantom detector array 
The Delta4 phantom (ScandiDos, Uppsala, 
Sweden) consists of 1069 cylindrical diodes (1 
mm diameter, 0.05 mm height, and 0.04 mm3 
volume) made of p-type silicon placed on two 
perpendicular arrays in a cylindrical polymethyl 
methacrylate (PMMA) phantom. Other features 
of Delta4 were reported previously (14, 15).  
In this study, the Delta4 diode arrays were 
utilized to measure the 2D and 3D dose distribu-
tions and compared using gamma index to those 
calculated by EclipseTM TPS.  
 
Treatment planning and irradiation 
Two different IMRT plans were designed for 
the heterogeneous chest phantom. The target 
tissue for the first plan (A) was between the left 
lung and the surrounding soft tissue and for the 
second plan (B), the target tissue was inside the 
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soft tissue. For the treatment planning, a                 
computed tomography (CT) scan was taken of 
the heterogeneous phantom and then was             
entered to EclipseTM TPS version 13.0.20 (Varian 
Medical Systems, Palo Alto, CA) to produce  
treatment plans of A and B as well as make dose 
calculations at various points using Anisotropic 
Analytical Algorithm (AAA) with a grid size of 
2.5 mm. The CT system (Siemens Somatom  
Emotion 16, Siemens, Germany) was 16-slice 
and slice thickness was chosen at 1 mm. For 
dose calculation, accuracy of Eclipse™ TPS, two 
IMRT plans with 7 fields were used and dynamic 
multi leaf collimator modulated to deliver 2Gy 
dose to the selected PTV in one session. The              
collimator angles were zero in all gantry angles.  
The treatment plan was transferred to the 
TPS with the films placed inside the                          
heterogeneous chest phantom for dose                 
distribution measurement. Positioning the  
phantom was done based on the plan conditions 
and the phantom was exposed with 6 MV X-rays 
emitted from a Varian clinic 600 linac (Varian 
Medical Systems, Palo Alto, CA). All conditions 
including the maintenance and film scan               
procedure were followed according to the film 
calibration instructions. In the next step, the  
Delta4 phantom was irradiated based on the 
same treatment planning and dose distribution 
was obtained using diode arrays. 
 
Statistical analysis 
In the current study, a global gamma index 
with standard criterion (distance-to -agreement 
(DTA) = 3 mm and dose difference (DD) = 3%) 
was chosen to compare the measured (Dm) and 
calculated (Dc) dose distributions (16). In                    
addition, the 20% dose threshold was                  
considered for all dose distribution points. The 
95% point agreement between TPS calculations 
and measurements was considered as a passing 
value for QA of TPS. Also, the gamma indices 
with 2 mm/2%, 4 mm/4%, and 5 mm/5%               
criteria were obtained at a dose threshold of 5, 
10, and 20% for further comparisons as well as 
evaluation of the film and Delta4.  
The differences between the gamma index 
values obtained from the film measurements 
with TPS calculations (2D) as well as Delta4 
measurements with TPS calculations (2D and 
3D) were specified by using Bland-Altman           
analysis (17). In this method, the x and y                     
coordinates are the mean and difference the  
between gamma value and the two involved          
detectors, respectively. The horizontal lines are 
the mean value of this difference and the mean 
value ±1.96 standard deviation (that is, 95%  
level agreement). 
 
 
RESULTS 
 
EBT3 film calibration curve 
The calibration curves of the film were                  
obtained in three channels (RGB), as shown in 
figure 1 with corresponding colors. The formula 
of each curve was calculated in 10-300 cGy               
doses using Microsoft Excel software, based on 
the OD-dose curve and the method proposed by 
Devic et al. (13). Goodness of the ﬁt parameters 
implied an exact three-polynomial ﬁtting in              
10-300 cGy dose range for all three calibration 
curves. It was found that the red channel curve 
was more sensitive than the green and blue 
channels.  
 
Dosimetric verification of EclipseTM TPS 
Figure 2 presents the isodose lines as well as 
dose normalized to the maximum dose, resulting 
from the film and Delta 4 in comparison with the 
TPS dose calculations. 
Table 1 summarizes the passing rates of  
global gamma index of the EBT3 film (2D) and 
Delta4 (2D and 3D). The passing criteria were 
chosen as 2 mm/2%, 3mm/3%, 4 mm/4%, and 
5 mm/5% as well as a dose threshold of 5, 10, 
and 20% for both A and B planes.  
The points accepted by the gamma index for 
both the film and Delta4 were higher than 95% 
with 3mm/3% criteria and 20% dose threshold 
(standard criteria in this study) for both A and B 
plans. Table 1 shows that the mean passing rates 
of gamma index (for both plans) with standard 
passing criteria were equal to 96.95±0.22%, 
97.70±0.56% and 98.45±0.21% for EBT3 film, 
2D Delta4, and 3D Delta4, respectively.                 
Additionally, the findings demonstrated that the 
mean passing rate of gamma value increased 
Abedi Firouzjah et al. / Dosimetric verification of EclipseTM TPS 
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when higher DTA and DD criteria were used.  
The mean passing rates of gamma index of 
the 3D Delta4 with standard criteria were 0.75 
and 1.5% higher than the 2D Delta4 and film, 
respectively. Also, the mean passing rates of 
gamma index of the film (2D) and Delta4 (2D 
and 3D) in plan B with standard criteria was 
0.24% higher than plan A (97.70% vs. 97.46%).  
 
Comparison between the EBT3 film and              
Delta4 phantom gamma index 
Findings  showing  the  comparison   between  
the passing rates of gamma index of the film and 
Delta4 are represented in figure 3. Parts of a and 
b are related to the comparison of film against 
2D-Delta4 and film against 3D-Delta4                        
measurements for both plans, respectively. The 
results showed that the mean differences                 
between the passing rate of gamma index of the 
film and 2D-Delta4, SD of bias, and 95% limits of 
agreement (mean value ±1.96 SD) were 1.24, 
1.83 and -2.35-4.83%, respectively, while the 
values for film and 3D-Delta4 were equal to 3.65, 
4.77, and -5.7-13.01%, respectively. 
Abedi Firouzjah et al. / Dosimetric verification of EclipseTM TPS 
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Figure 2. Comparisons of isodose distributions of measurements (dotted lines) and TPS calculations (solid lines) for plan A (a and 
c) and plan B (b and d) of IMRT using film (top) and Delta4 system (down). Plan A and plan B were designed between the left lung 
and the surrounding soft tissue and on the soft tissue, respectively. 
Figure 1. The film calibration curve, showing a greater sensitivity to the red channel.  
D
ow
nl
oa
de
d 
fro
m
 ijr
r.c
om
 at
 20
:45
 +0
43
0 o
n W
ed
ne
sd
ay
 M
ay
 29
th 
20
19
Abedi Firouzjah et al. / Dosimetric verification of EclipseTM TPS 
359 Int. J. Radiat. Res., Vol. 17  No. 2, April 2019 
Gamma Value for Plan B Gamma Value for Plan A  
Delta4 & TPS 
(3D) 
Delta4 & TPS 
(2D) 
Film & TPS 
Delta4 & TPS 
(3D) 
Delta4 & TPS 
(2D) 
Film & TPS  
87.5 84.8 79.1 82.7 81.5 75 
Points with Γ ≤1 (%) 
2 mm/2%- Threshold (5%) 
85.9 82 80.3 79.7 79 74.1 
Points with Γ ≤1 (%) 
2 mm/2%- Threshold (10%) 
84.8 80.5 81.9 78.3 77.3 89.5 
Points with Γ ≤1 (%) 
2 mm/2%- Threshold (20%) 
98.8 98.2 94.9 98.6 97.9 86.7 
Points with Γ ≤1 (%) 
3 mm/3%- Threshold (5%) 
98.7 97.9 96 98.4 97.5 86.1 
Points with Γ ≤1 (%) 
3 mm/3%- Threshold (10%) 
98.6 97.6 97.1 98.3 97.3 96.8 
Points with Γ ≤1 (%) 
3 mm/3%- Threshold (20%) 
100 100 98 100 100 91.9 
Points with Γ ≤1 (%) 
4 mm/4%- Threshold (5%) 
100 100 98.6 100 100 91.4 
Points with Γ ≤1 (%) 
4 mm/4%- Threshold (10%) 
100 100 99.4 100 100 98.3 
Points with Γ ≤1 (%) 
4mm/4%- Threshold (20%) 
100 100 99.1 100 100 95.3 
Points with Γ ≤1 (%) 
5mm/5%- Threshold (5%) 
100 100 99.4 100 100 95 
Points with Γ ≤1 (%) 
5mm/5%- Threshold (10%) 
100 100 99.8 100 100 98.9 
Points with Γ ≤1 (%) 
5mm/5%- Threshold (20%) 
Table 1. Comparison of passing rates of gamma index with different passing criteria for Plan A and plan B between TPS dose dis-
tribution calculation with film (2D) and Delta4 (2D and 3D) measurements in different criteria and dose thresholds. Plan A and Plan 
B were designed between the left lung and the surrounding soft tissue and on the soft tissue, respectively. 
Figure 3. Bland–Altman agreement plots for film against 2D-Delta4 measurements (a) and film against 3D-Delta4 measurements 
(b). The upper and lower lines represent the 95% standard deviation and the middle lines show the mean value. 
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DISCUSSION 
As indicated in table 1, the accuracy of dose 
calculations of EclipseTM TPS in a heterogeneous 
chest phantom with the IMRT technique is            
within standard passing criterion (3%/3mm). 
The findings show that the TPS has a good 
agreement with these two systems. The mean 
passing rates of gamma index between the film 
and Delta4 with TPS were not 100% equal. The 
decreased passing rate of gamma index between 
the film and TPS may be due to the lack of               
insufficient precision of the treatment setup and 
calibration curve. The inaccurate registration of 
the TPS plan and uncertainty of the scanner           
reproducibility could be considered as other  
factors. Also, the decreased passing rate of             
gamma index between Delta4 and TPS may have 
resulted from the different computational               
algorithms in the TPS and Delta4 phantom; as 
EclipseTM TPS and Delta 4 phantom employ AAA 
and Pencil Beam algorithm, respectively.                   
Another reason may be that the diode grid              
resolution was very low to accurately obtain the 
energy fluence applied to dose calculations 
(18).  In a study by Kan et al. (19), the accuracy of 
doses calculated by AAA and Acuros XB                   
algorithm was evaluated by EBT3 film within 
and adjacent to heterogeneous medium using 
IMRT plan for nasopharygeal carcinoma. Their 
findings showed that both algorithms exhibited 
acceptable accuracy in comparison with the 
measured data. In another study, Sini et al. (20) 
investigated the dosimetric accuracy of AAA, 
pencil beam Algorithm, and collapsed cone               
convolution superposition Algorithm in thoracic 
tumors for different IMRT techniques. Their           
results generally demonstrated a satisfactory 
agreement (<2%) between calculated and  
measured doses for AAA and collapsed cone 
convolution superposition Algorithm. 
With regard to the results presented in table 
1, the mean passing rates of gamma index varied 
with changing DTA and DD criteria. For example, 
the obtained passing rate of gamma index with 
2mm/2% criteria were less than 95% for both 
plans, due to a higher accuracy of the                      
measurements and increased computational  
error record. Chandraraj et al. (10) reported        
similar results for four commercial systems. 
They showed when stricter gamma index                
criteria were applied, some of the treatment 
plans failed to pass the tolerance. 
Table 1 indicates that the passing rates of 
gamma index between TPS and Delta4 are better 
in 3D distribution than in 2D. The reason for this 
could be that in the 3D situation, more                 
comparison points contribute to the agreement, 
therefore it would have a higher passing rate. 
Raiasekaran et al. (21), reported the same results 
but using Octavius phantom. Based on their  
findings, 3D planar gamma analysis showed             
better results than the 2D one because of                  
applying extra search dimension for evaluating 
the gamma, which leads to passing the pixel in 
the planar dose distribution using the 3D              
gamma analysis. 
The differences between passing rates of 
gamma index of the film (2D) and Delta4 (2D 
and 3D) were less than 5% and this discrepancy 
was higher for the 3D-Delta4 gamma index with 
the film compared to the 2D-Delta4 gamma               
index with the film. Based on the Bland-Altman 
analysis, three points lay outside the two                  
surrounding lines (±1.96 SD). These points were 
associated with the passing criterion of gamma 
index of 2mm/2% which could be due to the 
highest difference between film and Delta4  
gamma index in this criterion. Banci et al. (22) 
provided a comparison between the                         
MapCHECK™ diode array and the film. They            
reported that the differences in all of the outer 
points depend on the particular spatial                
distribution of the dose.  
 
 
CONCLUSION 
 
The results of this study indicate that the             
accuracy of dose calculations of EclipseTM TPS in 
a heterogeneous chest phantom with the IMRT 
technique is satisfactory. In other words, the 
passing rate of gamma index of the film and            
Delta4 phantom with a standard passing                  
criterion (3mm/3%) and a dose threshold of 
20% was higher than 95%. Furthermore, the 
differences between the passing rates of the 
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gamma index of the film and Delta4 were less 
than 5% and it can be concluded that there is a 
good agreement between the film and Delta4, as 
IMRT QA devices.  
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